Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Open Access
- 1 March 2003
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 31 (6), 481-486
- https://doi.org/10.1038/sj.bmt.1703798
Abstract
Adenovirus is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation and there is no established therapy. Cidofovir has in vitro efficacy against adenovirus. We performed a retrospective analysis of 45 patients treated with cidofovir for adenovirus from 10 centers. In total, 16 patients had definite adenovirus disease, 13 probable disease, and 16 asymptomatic infections. A total of 31 (69%) patients were successfully treated with cidofovir, 10 failed, and four were not evaluable owing to early death from other causes. Cidofovir therapy was successful in 10 patients with adenovirus disease, 10 patients with probable disease, and in 10 patients with asymptomatic infections. The overall survival at 28 days and 6 months after initiation of cidofovir therapy was 76 and 46%, respectively. Of the patients, 18 developed toxicity associated with cidofovir: 14 developed renal toxicity and four other types of toxicities. We conclude that cidofovir may be useful against adenovirus after allogeneic hematopoietic stem cell transplantation but additional studies are needed.Keywords
This publication has 16 references indexed in Scilit:
- Adenovirus Infections in Adult Recipients of Blood and Marrow TransplantsClinical Infectious Diseases, 2001
- Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipientsBlood, 2001
- Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantationBone Marrow Transplantation, 2000
- Adenovirus Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 1999
- Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapyBone Marrow Transplantation, 1999
- Adenovirus infection after pediatric bone marrow transplantationBone Marrow Transplantation, 1999
- Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zeland rabbit ocular modelAntiviral Research, 1996
- Increasing Incidence of Adenovirus Disease in Bone Marrow Transplant RecipientsThe Journal of Infectious Diseases, 1994
- Viral infections in pediatric bone marrow transplant patientsThe Pediatric Infectious Disease Journal, 1988
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985